Efficacy of dendrimer‐mediated angiostatin and TIMP‐2 gene delivery on inhibition of tumor growth and angiogenesis: In vitro and in vivo studies

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Journal of Cancer

• Publication date

  2003-06-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.11105PMID 12704680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix Metalloproteinase Inhibitors: Applications in Oncology

  2004cited by this paper
• Optimisation of dendrimer‐mediated gene transfer by anionic oligomers

  2003cited by this paper
• Antiangiogenic scheduling of lower dose cancer chemotherapy.

  2001cited by this paper
• Angiogenesis and antiangiogenic approaches to sarcomas

  2001cited by this paper
• Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.

  2001cited by this paper
• Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.

  2001cited by this paper
• Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.

  2001cited by this paper
• AdTIMP-2 Inhibits Tumor Growth, Angiogenesis, and Metastasis, and Prolongs Survival in Mice

  2001cited by this paper
• Anti-angiogenic agents: clinical trial design and therapies in development.

  2000cited by this paper
• Generation of Expression Plasmids for Angiostatin, Endostatin and Timp-2 for Cancer Gene Therapy

  1999cited by this paper
• Clinical studies with matrix metalloproteinase inhibitors

  1999cited by this paper
• Angiogenesis Activators and Inhibitors Differentially Regulate Caveolin-1 Expression and Caveolae Formation in Vascular Endothelial Cells

  1999cited by this paper
• Matrix‐degrading proteases and angiogenesis during development and tumor formation

  1999cited by this paper
• Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium

  1999cited by this paper
• Efficient Transfer of Genes into Murine Cardiac Grafts by Starburst Polyamidoamine Dendrimers

  1998cited by this paper
• Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.

  1998cited by this paper
• Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest.

  1998cited by this paper
• Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

  1998cited by this paper
• A monoclonal antibody directed against an epitope in the NH2-terminal region of native human plasminogen induces a modification of its functional properties

  1997cited by this paper
• Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

  1997cited by this paper
• Targeting gene therapy to cancer: a review.

  1997cited by this paper
• Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery.

  1997cited by this paper
• Approaches to enhance cancer radiotherapy employing gene transfer methods.

  1996cited by this paper
• Kringle Domains of Human Angiostatin

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.

  1996cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• HMEC-1: establishment of an immortalized human microvascular endothelial cell line.

  1992cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper
• Transplacental carcinogenesis by stilbestrol.

  1971cited by this paper

• Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment—An Overview

  2023cites this paper
• Dendrimer as nanocarrier for drug delivery and drug targeting therapeutics: a fundamental to advanced systematic review

  2022cites this paper
• Toward Gene Transfer Nanoparticles as Therapeutics

  2022cites this paper
• Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect

  2021cites this paper
• Application of Dendrimers for Treating Parasitic Diseases

  2021cites this paper
• Development of a PAMAM Dendrimer for Sustained Release of Temozolomide against Experimental Murine Lymphoma: Assessment of Therapeutic Efficacy.

  2021cites this paper
• Molecular approaches for targeted drug delivery towards cancer: A concise review with respect to nanotechnology

  2020cites this paper
• Anti-vascular nano agents: a promising approach for cancer treatment.

  2020cites this paper
• Dendrimers and hyperbranched structures for biomedical applications

  2019cites this paper
• Controlled Release Systems Targeting Angiogenesis

  2019cites this paper
• Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles.

  2019cites this paper
• Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery

  2019cites this paper
• Dendrimers: A versatile nanocarrier for drug delivery and targeting

  2018cites this paper
• Gene delivery nanoparticles to modulate angiogenesis☆

  2017cites this paper
• Anti-angiogenic Potential of VEGF Blocker Dendron-laden Gellan Gum Hydrogels for Tissue Engineering Applications

  2016cites this paper
• POTENTIAL APPLICATION OF DENDRIMERS IN DRUG DELIVERY: A CONCISE REVIEW AND UPDATE

  2016cites this paper
• Dendrimers for gene therapy

  2016cites this paper
• DENDRIMERS IN DRUG DELIVERY, DIAGNOSIS AND THERAPY: BASICS AND POTENTIAL APPLICATIONS

  2016cites this paper
• Mixed brush made of 4-arm stars and linear chains: MD simulations.

  2016cites this paper
• Theoretical approaches to starlike polymer brushes in Θ-solvent

  2016cites this paper
• The structure of brushes made of dendrimers: Recent advances

  2016cites this paper
• Recent advances in targeted drug delivery approaches using dendritic polymers.

  2015cites this paper
• Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction.

  2015cites this paper
• Nanocapsules in Biomedicine: Promises and Challenges

  2015cites this paper
• Fluorescein labelled cationic carbosilane dendritic systems for biological studies

  2015cites this paper
• Radiolabeling optimization and characterization of (68)Ga labeled DOTA-polyamido-amine dendrimer conjugate - Animal biodistribution and PET imaging results.

  2015cites this paper
• Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery.

  2015cites this paper
• Targeted Delivery of Nucleic Acid Therapeutics via Nonviral Vectors

  2015cites this paper
• Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells

  2015cites this paper
• Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications

  2014cites this paper
• Starlike polymer brushes in Θ-solvent

  2014cites this paper
• Next Generation Delivery System for Proteins and Genes of Therapeutic Purpose: Why and How?

  2014cites this paper
• Basic amino acid-conjugated polyamidoamine dendrimers with enhanced gene transfection efficiency

  2014cites this paper
• Formulation and Evaluation of Pamam Dendrimer Based Ocular Drug Delivery of Diclofenac Sodium

  2014cites this paper
• Structure of Dendrimer Brushes: Mean-Field Theory and MD Simulations

  2014cites this paper
• The adsorption-desorption transition of double-stranded DNA interacting with an oppositely charged dendrimer induced by multivalent anions.

  2014cites this paper
• A Multi-Scale Hybrid Nanoparticle Platform with Controlled Cellular Interaction and Targeting Kinetics

  2013cites this paper
• Poly(amidoamine) dendrimer complexes as a platform for gene delivery

  2013cites this paper
• Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.

  2013cites this paper
• Supplemental Table 1: Studies Utilizing In Vitro Tube Formation Assay Manuscript Authors Reference Identifier Newly synthesized quinazolinone HMJ-38 suppresses angiogenetic responses and triggers human umbilical vein endothelial cell apoptosis through p53-modulated Fas/death receptor signaling.

  2013cites this paper
• Nanoparticles as 'smart' pharmaceutical delivery.

  2013cites this paper
• Poly-ɛ-lysine dendron aptamers as regulators of angiogenesis in tissue regeneration

  2013cites this paper
• Unfortunately, we are not able (copyrights restrictions) to present you the final version which was improved after reviewers' comments. But, the main ideas of our review in this initial version are also presented.

  2013cites this paper
• Dendrimers as macromolecular tools to tackle from colon to brain tumor types: a concise overview

  2013cites this paper
• The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

  2012cites this paper
• Dendrimer-Based Gene Delivery Systems: Administration Routes and In Vivo Evaluation

  2012cites this paper
• Dendritic nanoparticles: the next generation of nanocarriers?

  2012cites this paper
• Highly organized self-assembled dendriplexes based on poly(propylene imine) glycodendrimer and anti-HIV oligodeoxynucleotides.

  2012cites this paper
• Conditionally Replicating Adenovirus Expressing TIMP2 Increases Survival in a Mouse Model of Disseminated Ovarian Cancer

  2011cites this paper
• Structurally Diverse Nitric Oxide-Releasing Poly(propylene Imine) Dendrimers.

  2011cites this paper
• Nonviral gene delivery in neural progenitors derived from human pluripotent stem cells.

  2011cites this paper
• Dendrimer biopharmaceutics : toward active dendrimer-cannabinoid drugs

  2011cites this paper
• Evaluating the gene-expression profiles of HeLa cancer cells treated with activated and nonactivated poly(amidoamine) dendrimers, and their DNA complexes.

  2010cites this paper
• Urocanic acid improves transfection efficiency of polyphosphazene with primary amino groups for gene delivery.

  2010cites this paper
• Increase in tissue inhibitor of metalloproteinase-2 (TIMP-2) levels and inhibition of MMP-2 activity in a metastatic breast cancer cell line by an anti-invasive small molecule SR13179.

  2010cites this paper
• How to study dendriplexes II: Transfection and cytotoxicity.

  2010cites this paper
• Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies—A review

  2010cites this paper
• Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth

  2010cites this paper
• Enhanced gene transfection efficiency by polyamidoamine (PAMAM) dendrimers modified with ornithine residues.

  2010cites this paper
• The ability of a collagen/calcium phosphate scaffold to act as its own vector for gene delivery and to promote bone formation via transfection with VEGF(165).

  2010cites this paper
• Dendrimer nanocarriers as versatile vectors in gene delivery.

  2009cites this paper
• Dendrimers in gene transfection

  2009cites this paper
• Preparation and in vitro studies of microencapsulated cells releasing human tissue inhibitor of metalloproteinase-2

  2008cites this paper
• Automatic Detection of In Vitro Capillary Tube Network in a Matrigel Analysis

  2008cites this paper
• Dendrimers as drug carriers: applications in different routes of drug administration.

  2008cites this paper
• Charge Modification of Pharmaceutical Nanocarriers: Biological Implications

  2008cites this paper
• Gene delivery to vascular endothelium using chemical vectors: implications for cardiovascular gene therapy

  2007cites this paper
• Nanoparticle‐Mediated Drug Delivery and Gene Therapy

  2007cites this paper
• Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies

  2007cites this paper
• Recklessness as a hallmark of aggressive cancer

  2007cites this paper
• A biologically active angiogenesis inhibitor, human serum albumin-TIMP-2 fusion protein, secreted from Saccharomyces cerevisiae.

  2007cites this paper
• Commentary: Engineering of Tissue Healing and Regeneration

  2007cites this paper
• 13 Dendrimers in Drug and Gene Delivery

  2006cites this paper
• Toxicity of cationic lipids and cationic polymers in gene delivery.

  2006cites this paper
• Nanotechnology: Intelligent Design to Treat Complex Disease

  2006cites this paper
• Macromolecular MRI contrast agents for imaging tumor angiogenesis.

  2006cites this paper
• PEGylated Dendritic Nanoparticulate Carriers of Anti-Cancer Drugs

  2006cites this paper
• Preferential liver gene expression with polypropylenimine dendrimers.

  2005cites this paper
• Preparation and in vitro studies of microencapsulated cells releasing human tissue inhibitor of metalloproteinase-2.

  2005cites this paper
• Designing dendrimers for biological

  2005cites this paper
• Dendrimers as DNA carriers

  2005cites this paper
• Micro and nano drug delivery systems in cancer therapyArticle

  2005cites this paper
• Comportement de cellules osseuses humaines en culture en présence du lipopeptide Ea-KRFK et au contact d'un revêtement phosphocalcique en vue de la fonctionnalisation de biomatériaux

  2005cites this paper
• Dendrimers in gene delivery B

  2005cites this paper
• Non-viral and viral vectors for gene therapy.

  2005cites this paper
• Dendrimers in gene delivery.

  2005cites this paper
• In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.

  2005cites this paper
• Dendrimer biocompatibility and toxicity.

  2005cites this paper
• Designing dendrimers for biological applications

  2005cites this paper
• Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie.

  2004cites this paper
• An overview of current delivery systems in cancer gene therapy.

  2004cites this paper
• Novel Function of Ascorbic Acid as an Angiostatic Factor

  2004cites this paper
• Cationic Dendrimers as Gene Transfection Vectors: Dendri -Poly(amidoamines) and Dendri -Poly(propylenimines)

  2004cites this paper
• Cationic compounds used in lipoplexes and polyplexes for gene delivery.

  2004cites this paper
• Tissue Inhibitors of Metalloproteinase 2 Inhibits Endothelial Cell Migration through Increased Expression of RECK

  2004cites this paper